AR021371A1 - Aposito - Google Patents

Aposito

Info

Publication number
AR021371A1
AR021371A1 ARP990105954A AR021371A1 AR 021371 A1 AR021371 A1 AR 021371A1 AR P990105954 A ARP990105954 A AR P990105954A AR 021371 A1 AR021371 A1 AR 021371A1
Authority
AR
Argentina
Prior art keywords
skin
absorbent substrate
useful
contained
active
Prior art date
Application number
Other languages
English (en)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of AR021371A1 publication Critical patent/AR021371A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Los apositos del invento comprenden por o menos dos componentes: un sustrato absorbente teniendo una primera superficie que mira a la piel y una segundasuperficie opuesta; y un revestimiento discontinuo de una composicion semi-solida dando unasensac ion de tipo unguento yaciendo sobre una porcion de la primerasuperficie de dicho sustrato absorbente. El sustrato absorbente es util como un dispensador pasivo de por lo menos un ingrediente activo que puede estarcontenido allí dentro. Elrevestimien to discontinuo es esencialmente no adherente a la piel y es util como un dispensador activo de por lo menos un ingredienteactivo que puede estar contenido allí dentro. En realizaciones preferidas el aposito del invento contiene por lomenos uno y más preferiblemente por lo menosdos, ingredientes activos para proveer beneficio terapéutico a la piel.
ARP990105954 1998-11-24 1999-11-23 Aposito AR021371A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19914298A 1998-11-24 1998-11-24

Publications (1)

Publication Number Publication Date
AR021371A1 true AR021371A1 (es) 2002-07-17

Family

ID=22736400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105954 AR021371A1 (es) 1998-11-24 1999-11-23 Aposito

Country Status (11)

Country Link
EP (1) EP1133325B1 (es)
JP (1) JP4558208B2 (es)
CN (1) CN1188176C (es)
AR (1) AR021371A1 (es)
AU (1) AU1825200A (es)
BR (1) BR9915621B1 (es)
CA (1) CA2350594A1 (es)
CO (1) CO5100944A1 (es)
DE (1) DE69930297T2 (es)
WO (1) WO2000030694A1 (es)
ZA (1) ZA200105134B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
KR100510169B1 (ko) * 2003-11-25 2005-08-24 김택영 탈지면에 분리망이 형성된 메쉬코튼과 그 제조방법
JP2005168723A (ja) * 2003-12-10 2005-06-30 Nissei Kk 吸収性貼付シート
GB0410749D0 (en) * 2004-05-14 2004-06-16 Dow Corning Ireland Ltd Coating apparatus
US20060178609A1 (en) 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
WO2006088912A2 (en) 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
JP4783429B2 (ja) * 2006-07-06 2011-09-28 株式会社瑞光 創傷被覆材
DE102007002073A1 (de) * 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
EP2745822A1 (de) * 2011-06-09 2014-06-25 Paul Hartmann AG Wundauflage, enthaltend Vliesstoff und Salbengrundlage, zur Unterdrucktherapie
KR102189877B1 (ko) 2012-06-22 2020-12-14 지-메디카 엘엘씨 지혈 장치
EP2944565B1 (en) 2014-05-13 2017-09-27 Entrotech, Inc. Erosion protective sleeve
EP2995324A1 (en) * 2014-09-11 2016-03-16 Mölnlycke Health Care AB Medical dressing
JP2016198170A (ja) * 2015-04-08 2016-12-01 国立大学法人 鹿児島大学 創傷被覆材および創傷被覆材の製造方法
CN108135787B (zh) 2015-10-22 2022-05-17 宝洁公司 发泡膜的阻隔贴片以及改善皮肤外观的方法
EP3365067B1 (en) 2015-10-22 2019-11-20 The Procter and Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017070078A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
EP3228329B1 (en) * 2016-04-06 2022-06-08 UPM-Kymmene Corporation A method for preparing a medical product comprising nanofibrillar cellulose and a medical product
CN105903056A (zh) * 2016-06-02 2016-08-31 四川奎星医用高分子制品有限责任公司 含有镇痛药物的医用复合海藻酸盐敷料及其制备方法
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
EP3565642A1 (en) 2017-01-09 2019-11-13 The Procter and Gamble Company Barrier patch with soluble film and methods of improving skin appearance
EP3641952B1 (en) 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
EP3768249B1 (en) 2018-03-19 2024-04-17 The Procter & Gamble Company Method of making a barrier patch with soluble film
CN111249516B (zh) * 2018-12-01 2020-12-22 浙江大学 一种含胰蛋白酶的止血织物及其制备方法
CN112121146B (zh) * 2019-06-25 2021-08-06 山东瑞安药业有限公司 一种用于皮肤创伤的外用凝胶剂及其制备方法
CN110393634A (zh) * 2019-06-28 2019-11-01 孙秀梅 一种用于治疗动静脉穿刺术后皮下损伤的治疗膜

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867150A (en) * 1987-01-20 1989-09-19 The B. F. Goodrich Company Perforated elastomeric soft film and wound dressing made therewith
DK158336C (da) * 1987-09-22 1990-10-01 Coloplast As Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf
GB8917790D0 (en) * 1989-08-03 1989-09-20 Smith & Nephew Adhesive dressing
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
US5814031A (en) * 1995-03-02 1998-09-29 Mooney; Mark Structured occllusive dressings

Also Published As

Publication number Publication date
CO5100944A1 (es) 2001-11-27
CN1188176C (zh) 2005-02-09
EP1133325A1 (en) 2001-09-19
ZA200105134B (en) 2002-06-21
JP4558208B2 (ja) 2010-10-06
AU1825200A (en) 2000-06-13
BR9915621A (pt) 2001-08-14
EP1133325B1 (en) 2006-03-08
CA2350594A1 (en) 2000-06-02
DE69930297D1 (de) 2006-05-04
JP2002530157A (ja) 2002-09-17
WO2000030694A1 (en) 2000-06-02
DE69930297T2 (de) 2006-11-30
BR9915621B1 (pt) 2011-07-26
CN1328475A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
AR021371A1 (es) Aposito
BRPI0514116A (pt) artigos absorventes compreendendo um agente modificador de exsudado corpóreo e uma formulação para cuidado da pele
ATE533478T1 (de) Missbrauchssichere opioide mit transdermalen systemen
ES2657216T3 (es) Apósito para la piel o para heridas para la cicatrización húmeda
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
AR033761A1 (es) Banda adhesiva
DE60318867D1 (de) Lösung zur nagel-verwendung
BR9915187A (pt) Esfregão pré-umidecido e regimen de tratamento da pele para aperfeiçoar ou manter a saúde da pele
DE60118885D1 (de) Nitratsalze von antimikrobiellen wirkstoffen
TR200101096T2 (tr) Depolanmaya elverişli formoterol içeren etken madde konsantresi
BR0308854A (pt) Benzazolas substituìdas e seus usos como inibidoras de quinase raf
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
PT1361903E (pt) Penso para feridas
DE60003647D1 (de) Druckentlastender wundverband
WO2002085288A3 (en) Stable antimicrobials in structured water
BR9814299A (pt) Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas
BR0307494A (pt) Composição que contêm extrato de palha de aveia e de erva de salgueiro
BR0316442A (pt) Composição
WO2010018559A3 (en) Formulations for a two-phase management of wound healing and dressings incorporating such formulations.
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
ES2137044T3 (es) Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica.
BR0100564A (pt) Estrutura compósita com matriz adesiva,contendo um ou vários ativos
MEP7809A (en) Use of docetaxel for treating hepatocellular carcinoma
ATE403420T1 (de) Transdermalsystem mit fentanyl
AR026038A1 (es) Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion

Legal Events

Date Code Title Description
FG Grant; registration